Quick Heal Technologies has appointed Harish Kumar GS as its Chief Executive Officer and Key Managerial Personnel effective June 18, 2026. The Board of Directors approved the appointment during its meeting held on June 18, 2026, based on the recommendation of the Nomination and Remuneration Committee. This strategic leadership move aims to leverage over three decades of industry experience to navigate the evolving cybersecurity landscape.

Leadership Profile

Harish Kumar GS brings extensive leadership experience across cybersecurity, enterprise software, technology infrastructure, networking, and digital services. Throughout his distinguished career, he has successfully led large-scale business transformations, accelerated growth, expanded market presence, and built high-performing teams across highly competitive technology markets. Prior to this appointment, he served as Head of Sales – India & SAARC at Check Point Software Technologies, where he played a pivotal role in driving business growth and strengthening the company's market leadership across the region.

Appointment Details

The key details of the leadership appointment are outlined below:

The appointment is in compliance with Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015.

Quick Heal Technologies has granted 2,20,000 stock options to employees under its ESOP Scheme 2021. The grant was approved by the company's Nomination and Remuneration Committee on June 18, 2026. This move aims to incentivize employees through equity participation, aligning their interests with the growth of the company.

The options are exercisable into 2,20,000 equity shares, each with a face value of ₹10. The pricing structure for the grant is divided into two categories. A total of 2,00,000 options have an exercise price of ₹10 each, while the remaining 20,000 options are priced at ₹87 each. The price of ₹87 represents a 50% discount based on the NSE closing share price on June 17, 2026.

Vesting and Exercise Details

The stock options come with specific vesting and exercise timelines designed to retain talent over the medium term. The options will vest after a minimum period of one year but no later than four years from the date of grant. Once vested, the options can be exercised by the holders to acquire an equivalent number of equity shares upon payment of the exercise price and applicable taxes.

All vested options must be exercised within a maximum period of three years from the date of vesting. This structure provides employees with a defined window to realize the benefits of their options, subject to the terms and conditions of the ESOP Scheme 2021.

Regulatory Compliance

The grant of options has been executed in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was submitted to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The following table summarizes the key details of the grant:

No options have been exercised, lapsed, or varied in terms at this stage. The company stated that diluted earnings per share calculations are not applicable at this current stage of the grant process.